Brief: Abionyx Pharma Completes A Capital Increase Of Around EUR 3 Mln

Abionyx Pharma SA

06/10/2023 06:34

Oct 6 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * COMPLETES A CAPITAL INCREASE IN FAVOR OF CATEGORIES OF
PERSONS
    * FOLLOWING DECISION TO ISSUE TAKEN BY BOARD OF DIRECTORS ON
OCTOBER 5, CHIEF EXECUTIVE OFFICER NOTED TODAY FULL SUBSCRIPTION
OF 2,967,352 NEW SHARES AT A PRICE OF EUR 1.011 PER SHARE
    * SUCCESSFUL COMPLETION OF A CAPITAL INCREASE OF AROUND EUR
3,000,000
    * FINANCIAL VISIBILITY EXTENDED TO Q1 2025 WITHOUT DRAWING
ON THE
EQUITY-LINKED FINANCING FACILITY
    * NEW SHARES WILL CARRY DIVIDEND RIGHTS, WILL BE ASSIMILATED
TO
EXISTING SHARES AND WILL ENJOY SAME RIGHTS
    * THE NUMBER OF SHARES ISSUED REPRESENTS AROUND 10.21% OF
THE
NUMBER OF SHARES IN CIRCULATION BEFORE ISSUE AND 9.27% AFTER
ISSUE
    * NEW SHARES WILL BE ADMITTED TO TRADING ON EURONEXT ON SAME
LINE
AS EXISTING SHARES
    * PURPOSE OF THIS FUNDRAISING IS TO STRENGTHEN COMPANY'S
CASH
POSITION IN CONTEXT OF ITS DEVELOPMENT IN SEPSIS

Source text for Eikon:  ID:nBwbTNvTXa 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))